How Recent Developments Are Shaping the Ginkgo Bioworks Investment Story [Yahoo! Finance]
Ginkgo Bioworks Holdings, Inc. (DNA)
Company Research
Source: Yahoo! Finance
The discount rate has increased from 8.53% to 9.26% to account for a slightly higher risk profile. Analysts note that while revenue growth forecasts remain stable at about 5.22%, the outlook is shaped by both positive short-term developments and caution over long-term uncertainties. Stay tuned to discover how investors can track these evolving narratives and stay informed about future updates. Analyst Price Targets don't always capture the full story. Head over to our Company Report to find new ways to value Ginkgo Bioworks Holdings. What Wall Street Has Been Saying ?? Bullish Takeaways BTIG raised its price target on Ginkgo Bioworks Holdings to $9 from $6, reflecting increased confidence after a significant second-quarter topline beat. The company's ability to reduce costs faster than expected has been rewarded by analysts, highlighting strong execution and effective cost control. BTIG notes Ginkgo's reiteration of its primary goal to reach adjusted EBITDA breakeven by th
Show less
Read more
Impact Snapshot
Event Time:
DNA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DNA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DNA alerts
High impacting Ginkgo Bioworks Holdings, Inc. news events
Weekly update
A roundup of the hottest topics
DNA
News
- Ginkgo Bioworks Selected by PNNL to Deliver a Modular, High-Throughput Phenotyping Platform for DOE's M2PCPR Newswire
- STRM.BIO Awarded ARPA-H Contract to Advance Megakaryocyte-Derived Vesicle Platform for In Vivo Cell Engineering and Gene TherapyPR Newswire
- Will Ginkgo Bioworks (DNA) Leverage ARPA-H Partnership to Advance Its Oral Therapeutics Ambitions? [Yahoo! Finance]Yahoo! Finance
- Ginkgo Bioworks: Scaling Science, Not Revenue [Seeking Alpha]Seeking Alpha
- Ginkgo Bioworks (DNA): Rethinking Valuation After New University Collaboration in ARPA-H MIGHTY Oral Health Initiative [Yahoo! Finance]Yahoo! Finance
DNA
Earnings
- 11/6/25 - Miss
DNA
Sec Filings
- 11/14/25 - Form SCHEDULE
- 11/12/25 - Form 144
- 11/6/25 - Form 10-Q
- DNA's page on the SEC website